147 related articles for article (PubMed ID: 38199641)
21. The Pre-BRA (pre-pectoral Breast Reconstruction EvAluation) feasibility study: protocol for a mixed-methods IDEAL 2a/2b prospective cohort study to determine the safety and effectiveness of prepectoral implant-based breast reconstruction.
Harvey KL; Mills N; White P; Holcombe C; Potter S;
BMJ Open; 2020 Jan; 10(1):e033641. PubMed ID: 31988232
[TBL] [Abstract][Full Text] [Related]
22. Digital Phenotyping for Monitoring and Disease Trajectory Prediction of Patients With Cancer: Protocol for a Prospective Observational Cohort Study.
Jenciūtė G; Kasputytė G; Bunevičienė I; Korobeinikova E; Vaitiekus D; Inčiūra A; Jaruševičius L; Bunevičius R; Krikštolaitis R; Krilavičius T; Juozaitytė E; Bunevičius A
JMIR Res Protoc; 2023 Oct; 12():e49096. PubMed ID: 37815850
[TBL] [Abstract][Full Text] [Related]
23. Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance.
Banerjee AK; Okun S; Edwards IR; Wicks P; Smith MY; Mayall SJ; Flamion B; Cleeland C; Basch E;
Drug Saf; 2013 Dec; 36(12):1129-49. PubMed ID: 24092596
[TBL] [Abstract][Full Text] [Related]
24. Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial.
Hassett MJ; Wong S; Osarogiagbon RU; Bian J; Dizon DS; Jenkins HH; Uno H; Cronin C; Schrag D;
Trials; 2022 Jun; 23(1):506. PubMed ID: 35710449
[TBL] [Abstract][Full Text] [Related]
25. Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol.
Kyte D; Bishop J; Brettell E; Calvert M; Cockwell P; Dutton M; Eddington H; Hadley G; Ives NJ; Jackson LJ; Stringer S; Valente M
BMJ Open; 2018 Oct; 8(10):e026080. PubMed ID: 30373785
[TBL] [Abstract][Full Text] [Related]
26. The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer.
Maguire R; Fox PA; McCann L; Miaskowski C; Kotronoulas G; Miller M; Furlong E; Ream E; Armes J; Patiraki E; Gaiger A; Berg GV; Flowerday A; Donnan P; McCrone P; Apostolidis K; Harris J; Katsaragakis S; Buick AR; Kearney N
BMJ Open; 2017 Jun; 7(5):e015016. PubMed ID: 28592577
[TBL] [Abstract][Full Text] [Related]
27. Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT).
Maier RH; Plummer C; Kasim AS; Akhter N; Ogundimu E; Maddox J; Graham J; Stewart M; Wardley A; Haney S; Vahabi S; Oxenham H; Humphreys A; Cresti N; Verrill M; Graham R; Chang L; Hancock HC; Austin D
BMJ Open; 2022 Dec; 12(12):e066252. PubMed ID: 36585130
[TBL] [Abstract][Full Text] [Related]
28. Patient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial.
Parikh RB; Ferrell W; Wakim J; Williamson J; Khan N; Kopinsky M; Balachandran M; Gabriel PE; Zhang Y; Schuchter LM; Shulman LN; Chen J; Patel MS; Manz CR
BMJ Open; 2022 May; 12(5):e054675. PubMed ID: 35551088
[TBL] [Abstract][Full Text] [Related]
29. Chinese multicentre prospective registry of breast cancer patient-reported outcome-reconstruction and oncoplastic cohort (PRO-ROC): a study protocol.
Li L; Yang B; Li H; Yin J; Jin F; Han S; Liao N; Shi J; Ling R; Li Z; Ouyang L; Wang X; Fu P; Ouyang Z; Ma B; Wu X; Wang H; Liu J; Shao Z; Wu J
BMJ Open; 2019 Dec; 9(12):e032945. PubMed ID: 31843846
[TBL] [Abstract][Full Text] [Related]
30. Clinical validation of a public health policy-making platform for hearing loss (EVOTION): protocol for a big data study.
Dritsakis G; Kikidis D; Koloutsou N; Murdin L; Bibas A; Ploumidou K; Laplante-Lévesque A; Pontoppidan NH; Bamiou DE
BMJ Open; 2018 Feb; 8(2):e020978. PubMed ID: 29449298
[TBL] [Abstract][Full Text] [Related]
31. The Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review.
Beauchamp UL; Pappot H; Holländer-Mieritz C
JMIR Mhealth Uhealth; 2020 Nov; 8(11):e22006. PubMed ID: 33174852
[TBL] [Abstract][Full Text] [Related]
32. Connected device and therapeutic patient education to promote physical activity among women with localised breast cancer (DISCO trial): protocol for a multicentre 2×2 factorial randomised controlled trial.
Touillaud M; Fournier B; Pérol O; Delrieu L; Maire A; Belladame E; Pérol D; Perrier L; Preau M; Leroy T; Fassier JB; Fillol F; Pascal S; Durand T; Fervers B
BMJ Open; 2021 Sep; 11(9):e045448. PubMed ID: 34518245
[TBL] [Abstract][Full Text] [Related]
33. Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study).
Ma Y; Achiche S; Pomey MP; Paquette J; Adjtoutah N; Vicente S; Engler K; ; Laymouna M; Lessard D; Lemire B; Asselah J; Therrien R; Osmanlliu E; Zawati MH; Joly Y; Lebouché B
JMIR Res Protoc; 2024 Feb; 13():e54668. PubMed ID: 38349734
[TBL] [Abstract][Full Text] [Related]
34. Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol.
Krzyzanowska MK; Julian JA; Powis M; Howell D; Earle CC; Enright KA; Mittmann N; Trudeau ME; Grunfeld E
BMC Cancer; 2019 Sep; 19(1):884. PubMed ID: 31488084
[TBL] [Abstract][Full Text] [Related]
35. What is multidisciplinary cancer care like in practice? a protocol for a mixed-method study to characterise ambulatory oncology services in the Australian public sector.
Nic Giolla Easpaig B; Arnolda G; Tran Y; Bierbaum M; Lamprell K; Delaney GP; Liauw W; Chittajallu R; Winata T; Ward RL; Currow DC; Olver I; Karnon J; Westbrook J; Braithwaite J
BMJ Open; 2019 Oct; 9(10):e031179. PubMed ID: 31601594
[TBL] [Abstract][Full Text] [Related]
36. Protocol for the ASTRO study (SSOP-01): a multicentre prospective cohort study investigating adverse events based on electronic patient-reported outcomes in patients with breast cancer after adjuvant chemotherapy.
Kuniyoshi O; Sano M; Nakano Y; Kawaguchi T; Hatakeyama T; Tsuchiya Y; Inada Y; Harada T; Kurosaki M; Mashiko T; Miyaji T; Yamaguchi T
BMJ Open; 2023 Sep; 13(9):e071500. PubMed ID: 37709306
[TBL] [Abstract][Full Text] [Related]
37. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
38. Utilizing Digital Health to Collect Electronic Patient-Reported Outcomes in Prostate Cancer: Single-Arm Pilot Trial.
Tran C; Dicker A; Leiby B; Gressen E; Williams N; Jim H
J Med Internet Res; 2020 Mar; 22(3):e12689. PubMed ID: 32209536
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal study of symptom burden in outpatients with advanced cancers based on electronic Patient-Reported Outcome (ePRO) platform: a single institution, prospective study protocol.
Tang L; Pang Y; He Y; Shi Q; Han X; Li Z; Zhou C; Zhou Y; He S; Wang Y; Zhang Y; Song L; Wang B; Li X
BMJ Open; 2020 Nov; 10(11):e038223. PubMed ID: 33444183
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
